Celldex Therapeutics, Inc. (CLDX) › RevenueCelldex Therapeutics, Inc. (CLDX) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $6.79M2017: $12.74M2018: $9.54M2019: $3.57M2020: $7.42M2021: $4.65M2022: $2.36M2023: $6.88M2024: $7.02M2025: $1.54M$1.54M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$1.54M-78.0%2024$7.02M+2.0%2023$6.88M+192.0%2022$2.36M-49.3%2021$4.65M-37.3%2020$7.42M+107.6%2019$3.57M-62.5%2018$9.54M-25.2%2017$12.74M+87.8%2016$6.79M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share